Mkts

PharmaCyte Biotech, Inc.

NASDAQ: PMCB
$0.42+0.06 (+15.31%)
As of Nov 9, 2:27 PM ET

Key statistics

Day range
0.360.43
52-week range
0.301.51
Today
Open0.37
Previous close0.42
Volume193.3K
Valuation
Market cap3.86M
P/E ratio—
EPS (TTM)-1.90
Income & risk
Dividend / yield—
Beta0.71
Avg volume174.6K
Discussion

PMCB News

Stories mentioning PMCB from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Jan 31Q4 '25Oct 31Q3 '25Jul 31Q2 '25Apr 30Q1 '25Jan 31Q4 '24Oct 31Q3 '24Jul 31Q2 '24Apr 30
Income Statement
Revenue0.000.000.000.000.000.000.000.00
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development93.00141.0095.00127.00118.0097.0096.0094.00
Sales General & Admin
Total Operating Expenses2,1181,376848.001,043960.001,1061,2693,166
Operating Income (Loss)(2,118)(1,376)(848.00)(1,043)(960.00)(1,106)(1,269)(3,166)
Interest Income
Interest Expense
Other Expense(1.00)0.000.000.000.00(1.00)0.00194.00
Pretax Income
Tax Provision
Net Income (Loss)747.00(7,418)(8,360)11,750(3,045)(1,470)23,4211,347
Earnings Per Share (Basic)(0.17)(1.24)(1.23)1.60(0.44)(0.39)1.900.14
Earnings Per Share (Diluted)(0.17)(1.24)(1.23)1.60(0.44)(0.39)1.900.14
Weighted Average Shares Outstanding (Basic)9,2636,7966,7967,3306,9607,6377,8669,581
Weighted Average Shares Outstanding (Diluted)9,2636,7966,7967,3306,9607,6377,8669,581

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About PMCB

PharmaCyte Biotech, Inc. (NASDAQ: PMCB) is a stock listed on the Nasdaq Stock Market under the ticker symbol PMCB. It last traded at $0.4200 (Nov 9, 2026, 2:27 PM ET), up 15.3% on the day. That gives PharmaCyte Biotech a market capitalisation of $3.9M.

Over the past 52 weeks PMCB has traded between $0.3000 and $1.51.

Revenue for the quarter ended Jan 31, 2026 was $0; net income $747.0K.

Last 4 quarters
Quarter endedRevenueNet income
Jan 31, 2026$0$747.0K
Oct 31, 2025$0-$7.4M
Jul 31, 2025$0-$8.4M
Apr 30, 2025$0$11.8M

From PharmaCyte Biotech’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…